$A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors$

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors

Mettu, Niharika B.; Niedzwiecki, Donna; Rushing, Christel; Nixon, Andrew B.; Jia, Jingquan; Haley, Sherri; Honeycutt, Wanda; Hurwitz, Herbert; Bendell, Johanna C.; Uronis, Hope

期刊名称Cancer Chemotherapy and Pharmacology
作者Mettu, Niharika B.; Niedzwiecki, Donna; Rushing, Christel; Nixon, Andrew B.; Jia, Jingquan; Haley, Sherri; Honeycutt, Wanda; Hurwitz, Herbert; Bendell, Johanna C.; Uronis, Hope
印刷ISSN0344-5704
电子ISSN1432-0843
文件大小821.21KB
发表时间2019-3-20
DOI10.1007/s00280-019-03805-6

发现好书期刊，享受阅读乐趣

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors